MEDIUM confidence: 100% data completeness, but the composite (44) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Not enough return history to estimate factor exposures — 29 of 36 months required. This stock is too recently listed (or has too short a price history) for a reliable Fama-French regression.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Net insider -$126.3M over 180 days (0 open-market buys, 97 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 39.1%/yr (revenue basis).
Base free cash flow $123M (avg FY2023–FY2025; latest year $282M) · equity value $43.5B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
| Metric (USD) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $80M— | $116M+45.0% | $396M+242.2% | $853M+115.1% |
| EPS (dil.) | $-0.45— | $-0.17n/m | $-0.64n/m | $1.22n/m |
| Free Cash Flow | -$40M— | -$15Mn/m | $102Mn/m | $282M+175.1% |
| Gross Margin | 73.5% | 68.9%-4.5pp | 76.4%+7.4pp | 75.7%-0.7pp |
| Operating Margin | -75.4% | -25.5%+49.9pp | -29.3%-3.8pp | 20.3%+49.6pp |
| Net Margin | -73.0% | -22.7%+50.4pp | -21.1%+1.6pp | 25.7%+46.8pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $401 avg across 8 analysts.
Buy-rated share 69% → 70% over ~3 months (+1pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $0.69 | $0.80 | +15.8% |
| May 2026 | $0.54 | $0.61 | +13.6% |
| Feb 2026 | $0.52 | $0.58 | +12.4% |
| Nov 2025 | $0.39 | $0.49 | +25.7% |
| Aug 2025 | $0.32 | $0.44 | +35.8% |
| May 2025 | $0.28 | $0.33 | +16.2% |
| Feb 2025 | $0.26 | $0.37 | +42.3% |
| Nov 2024 | $0.17 | $0.23 | +34.8% |
The QScore of 44 for ALAB suggests a neutral outlook, driven by a high growth score of 81, which reflects the company's strong revenue and earnings growth, including a notable 306.3% EPS growth. However, this is offset by a low value score of 25, due to the stock's premium valuation, with a P/E of 115.5 and EV/EBITDA of 129.9. The stock exhibits strong momentum over the past year, with a 49.0% return, but has recently declined, with a -19.4% return over the past three months.